Taysha Gene Therapies (TSHA)
(Real Time Quote from BATS)
$2.53 USD
-0.04 (-1.56%)
Updated May 6, 2024 01:12 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.11 | -9.09% |
Earnings Summary
For their last quarter, Taysha Gene Therapies (TSHA) reported earnings of $0.35 per share, beating the Zacks Consensus Estimate of $-0.09 per share. This reflects a positive earnings surprise of 488.89%. Look out for TSHA's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year increase of 60.71%.
Earnings History
Price & Consensus
Zacks News for TSHA
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
TSHA: What are Zacks experts saying now?
Zacks Private Portfolio Services